Nestlé RECOVER Dietary Supplement Patent - Therapeutic Applications
Summary
The European Patent Office published Patent EP3976088A1 for Nestlé S.A.'s RECOVER dietary supplement. The patent covers compositions including vitamins, minerals, and amino acids for therapeutic applications, particularly muscle function support (A61P 21/00). The patent is designated for all 31 European member states and extension countries.
What changed
The European Patent Office granted Patent EP3976088A1 to Nestlé S.A. for the RECOVER dietary supplement composition. The patent claims a combination of active ingredients including B vitamins (thiamine, riboflavin, niacin, B6, folate, B12), vitamin C, zinc, magnesium, selenium, and amino acids. The designated states include all major European markets (AL, AT, BE, DE, ES, FR, GB, IT, NL, PL, etc.).
Patent publications do not create compliance obligations for third parties. Competitors developing similar dietary supplement formulations should review the patent claims to assess potential infringement risks. No immediate action is required unless pursuing related product development in designated European territories.
Source document (simplified)
RECOVER DIETARY SUPPLEMENT
Publication EP3976088A1 Kind: A1 Mar 25, 2026
Applicants
Société des Produits Nestlé S.A.
Inventors
SEIDENSTICKER, Kurt, APORTA, Matt, FRIESE, Corey, SKUBAL, Angela
IPC Classifications
A61K 38/39 20060101AFI20230907BHEP A61K 33/30 20060101ALI20230907BHEP A61K 33/06 20060101ALI20230907BHEP A61K 33/04 20060101ALI20230907BHEP A61K 33/00 20060101ALI20230907BHEP A61K 31/675 20060101ALI20230907BHEP A61K 31/525 20060101ALI20230907BHEP A61K 31/51 20060101ALI20230907BHEP A61K 31/455 20060101ALI20230907BHEP A61K 31/375 20060101ALI20230907BHEP A61K 31/198 20060101ALI20230907BHEP A61K 31/185 20060101ALI20230907BHEP A23L 33/17 20160101ALI20230907BHEP A23L 33/16 20160101ALI20230907BHEP A23L 33/15 20160101ALI20230907BHEP A23L 2/39 20060101ALI20230907BHEP A61K 38/01 20060101ALI20230907BHEP A23L 33/18 20160101ALI20230907BHEP A23L 33/175 20160101ALI20230907BHEP A61P 21/00 20060101ALI20230907BHEP A61K 31/519 20060101ALI20230907BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Therapeutics (A61P) publishes new changes.